Healthcare

Western Europe Point-of-Care Testing (POCT) Market

INDUSTRY
Healthcare

RELEASE DATE
01-Jul-2016
REGION
Europe
DELIVERABLE TYPE
Market Research

RESEARCH CODE
MC01-01-00-00-00
SKU
HC02655-EU-MR_18715
Yes
SHARE

Western Europe Point-of-Care Testing (POCT) Market
Published on: 01-Jul-2016 | SKU: HC02655-EU-MR_18715

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the industry as well as anticipate new avenues of growth to innovate to new business models and capitalize on the transformation that the market is undergoing. It is pertinent to understand key convergences that drive POCT sector growth and the technological building blocks that contribute to the future functionality of this market. This study will enable vendors in this space to look at future opportunities in POCT industry from an application-/therapeutic-area point of view and organic/inorganic means to monetize these opportunities.

Executive Summary—Market Snapshot

Western Europe Revenue Share—Forecast

Scope and Segmentation

Trends/Factors Impacting the POCT Market

8 Big Themes for the POCT Market of the Future

  • Application Areas
  • Consumer Preference
  • Macroeconomic Factors
  • Technology Advancement

Market Definition

Growth Opportunity by Customer Segment

Is POCT a Viable Option in Western Europe?

Cost Considerations of POCT Implementation in Europe

Pharmacoeconomic Metrics

  • Blood Glucose Testing
  • Infectious Disease
  • Hb1Ac
  • Pregnancy
  • Cholesterol
  • Cardiac Markers
  • Rapid Coagulation
  • Drugs of Abuse
  • Urinalysis
  • Blood Gas and Electrolytes
  • Faecal Occult Test
  • Haematology

Quantifiable Benefits of POCT in the EU Setting

  • Home care*
  • Primary Care (POL & Retail)
  • Hospital Emergency Department
  • Independent Labs

Drivers and Restraints

  • Lab Tests
  • Point-of-Care Testing

Market Share by Top Competitors

  • Capital Costs
  • Variable Costs
  • Professional Costs
  • Other Fixed Costs

Market Share Across Segments

Market Size and Growth Graph

Market Overview

  • Market Drivers
  • Market Restraints

Top 3 Strategic Segments in Western Europe

Niche Therapeutic Applications to Drive Future Growth

New Technology Advancements in POCT

Key Companies to Watch in Western Europe

POCT Reimbursement Landscape of the Future

Emergence of iPOCT

iPOCT Architecture

Future Model of POCT Ecosystem

POCT Value Chain Stakeholders

POCT Vendor Landscape

Competitive Environment

Competitive Analysis

Merger, Acquisition, and Partnership Assessment

Forecasting Methodology

Revenue Forecast

Revenue Forecast

Competitive Structure

Revenue Forecast

Competitive Structure

Revenue Forecast

Competitive Structure

Revenue Forecast

Competitive Structure

Revenue Forecast

Competitive Structure

Revenue Forecast

Competitive Structure

Revenue Forecast

Competitive Structure

Revenue Forecast

Competitive Structure

Revenue Forecast

Competitive Structure

Revenue Forecast

Competitive Structure

Revenue Forecast

Competitive Structure

Revenue Forecast

Competitive Structure

Western Europe POCT Segment Metrics Analysis

Revenue Share by Region

Revenue Forecast

Revenue Forecast

Revenue Forecast

Revenue Forecast

Revenue Forecast

Revenue Forecast

Revenue Forecast

The Last Word—3 Big Predictions

Legal Disclaimer

Market Engineering Methodology

List of Figures
  • 1. POCT Market: Turnaround Time of Selected Key Tests, US and Western Europe, 2014
  • 2. Total POCT Market: Cost Analysis of Key Tests, Western Europe, 2014
  • 3. POCT Market: Key Market Drivers and Restraints, Western Europe, 2016–2020
  • 4. POCT Market: Competitive Structure, Western Europe, 2015
  • 5. Total POCT Market: Notable Deals and Market Impact, Western Europe, 2015 and 2016
  • 6. Infectious POCT Market: Competitive Structure, Western Europe, 2015
  • 7. Cardiac POCT Market: Competitive Structure, Western Europe, 2015
  • 8. Blood Glucose POCT Market : Competitive Structure, Western Europe, 2015
  • 9. Hb1Ac POCT Market: Competitive Structure, Western Europe, 2015
  • 10. Blood Gas and Electrolytes POCT Market: Competitive Structure, Western Europe, 2015
  • 11. Rapid Coagulation POCT Market: Competitive Structure, Western Europe, 2015
  • 12. Haematology POCT Market: Competitive Structure, Western Europe, 2015
  • 13. Pregnancy POCT Market: Competitive Structure, Western Europe, 2015
  • 14. Urinalysis POCT Market: Competitive Structure, Western Europe, 2015
  • 15. Cholesterol POCT Market: Competitive Structure, Western Europe, 2015
  • 16. Foecal Occult POCT Market: Competitive Structure, Western Europe, 2015
  • 17. Drugs of Abuse POCT Market: Competitive Structure, Western Europe, 2015
List of Charts
  • 1. Total POCT Market: Percent Revenue Share by Segment, Western Europe, 2016 and 2020
  • 2. Total POCT Market: Percent Sales Breakdown, Western Europe, 2015
  • 3. Western European POCT Market: Barriers to POCT Adoption, 2014
  • 4. POCT Market: Economic Drivers for POCT, Western Europe, 2015
  • 5. Total POCT Market: Percent Revenue Breakdown, Western Europe, 2015
  • 6. Total POCT Market: Percent Revenue Breakdown by Segment, Western Europe, 2015
  • 7. Total POCT Market: Revenue and CAGR by Segment, Western Europe, 2015
  • 8. Total POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 9. Infectious POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 10. Cardiac Testing POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 11. Blood Glucose POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 12. Hb1Ac POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 13. Blood Gas and Electrolytes POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 14. Rapid Coagulation POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 15. Haematology POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 16. Pregnancy POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 17. Urinalysis POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 18. Cholesterol POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 19. Fecal Occult POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 20. Drugs of Abuse POCT Market: Revenue Forecast, Western Europe, 2013–2020
  • 21. POCT Market: Percent Revenue by Region, Western Europe, 2015
  • 22. POCT Market: Revenue Forecast, UK, 2013–2020
  • 23. POCT Market: Revenue Forecast, Germany, 2013–2020
  • 24. POCT Market: Revenue Forecast, France, 2013–2020
  • 25. POCT Market: Revenue Forecast, Italy, 2013–2020
  • 26. POCT Market: Revenue Forecast, Spain, 2013–2020
  • 27. POCT Market: Revenue Forecast, Benelux, 2013–2020
  • 28. POCT Market: Revenue Forecast, Scandinavia, 2013–2020

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.